Publications
- Guidelines for alemtuzumab treatment in chronic lymphocytic leukemia (CLL)2012 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients2011 | Third Faculty of Medicine, Second Faculty of Medicine
- Heat-shock protein expression in leukemia2011 | Third Faculty of Medicine
- Can We Use EBV-DNA Monitoring to Predict Disease Relapse in EBV-Positive Hodgkin Lymphoma Patients?2010 | Third Faculty of Medicine, Second Faculty of Medicine
- Expression of heat shock protein 70 and NKG2D ligands in acute myeloid leukemia cell lines2010 | Third Faculty of Medicine
- Minimal residual disease in chronic lymphocytic leukemia: Detection methods and clinical significance2010 | Third Faculty of Medicine
- Risk factors in chronic lymphocytic leukemia, validation of flow cytometric detection using RT-PCR and immunohistochemistry2009 | Third Faculty of Medicine
- Nuclear myosin is ubiquitously expressed and evolutionary conserved in vertebrates2007 | Third Faculty of Medicine, Central Library of Charles University
- ZAP-70 in B-cell chronic lymphocytic leukemia: clinical significance and methods of detection2006 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...